Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal intelligence from Strategic Transactions.
PDL BioPharma Inc. made public its launch of a hostile bid to acquire Nasdaq-traded Neos Therapeutics Inc. on...